# Ontruzant

NDC: 78206-147
Generic name: trastuzumab
Labeler / Manufacturer: Organon LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210601

FDA application: BLA761100

## Active ingredients

- TRASTUZUMAB: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"78206-147"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=78206-147
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ce2a2492-85e3-4b0a-872a-047f44e4203d